| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$93 ) |
| | 2024 | 2021 | DORICPHARMA LLC | 2304 N 1ST AVE | UPLAND | CA | 91784-1301 | SAN BERNARDINO | USA | R41CA247009 | Using Targeted Lipid Nanoparticles to Deliver Chemotherapeutic Agents against Pancreatic Cancer | 000 | 1 | NIH | 5/2/2024 | -$93 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | DORICPHARMA LLC | 2304 N 1ST AVE | UPLAND | CA | 91784-1301 | SAN BERNARDINO | USA | R41CA247009 | Using Targeted Lipid Nanoparticles to Deliver Chemotherapeutic Agents against Pancreatic Cancer | 000 | 1 | NIH | 2/3/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2020 | DORICPHARMA LLC | 2304 N 1ST AVE | UPLAND | CA | 91784-1301 | SAN BERNARDINO | USA | R41CA247009 | Using Targeted Lipid Nanoparticles to Deliver Chemotherapeutic Agents against Pancreatic Cancer | 000 | 1 | NIH | 2/4/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $52,000 ) |
| | 2021 | 2021 | DORICPHARMA LLC | 2304 N 1ST AVE | UPLAND | CA | 91784-1301 | SAN BERNARDINO | USA | R41CA247009 | Using Targeted Lipid Nanoparticles to Deliver Chemotherapeutic Agents against Pancreatic Cancer | 000 | 1 | NIH | 2/22/2021 | $52,000 |
|
| Issue Date FY: 2020 ( Subtotal = $401,754 ) |
| | 2020 | 2020 | DORICPHARMA LLC | 2304 N 1ST AVE | UPLAND | CA | 91784-1301 | SAN BERNARDINO | USA | R41CA247009 | Using Targeted Lipid Nanoparticles to Deliver Chemotherapeutic Agents against Pancreatic Cancer | 000 | 1 | NIH | 3/5/2020 | $299,559 |
| | 2020 | 2020 | DORICPHARMA LLC | 2304 N 1ST AVE | UPLAND | CA | 91784-1301 | SAN BERNARDINO | USA | R41CA247009 | Using Targeted Lipid Nanoparticles to Deliver Chemotherapeutic Agents against Pancreatic Cancer | 001 | 1 | NIH | 9/24/2020 | $102,195 |
|
|
